Cardiovascular Drugs And Therapy SCIE

国际简称：CARDIOVASC DRUG THER 参考译名：心血管药物和治疗

主要研究方向：医学-心血管系统非预警期刊审稿周期：约4.5月

《心血管药物和治疗》(Cardiovascular Drugs And Therapy)是一本由Springer US出版的以医学-心血管系统为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q2 JCR分区
101 年发文量
3.1 IF影响因子
未开放 是否OA
63 H-index
1987 创刊年份
Bimonthly 出版周期
English 出版语言

Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field.

Homing in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focusses on developments in atherosclerosis, hyperlipidemia, diabetes, ischemic syndromes and arrhythmias. The Journal is an authoritative source of current and relevant information that is indispensable for basic and clinical investigators aiming for novel, breakthrough research as well as for cardiologists seeking to best serve their patients.

Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Web of Science and PubMed/Medline among other abstracting and indexing services. The regular articles and frequent special topical issues equip you with an up-to-date source defined by the need for accurate information on an ever-evolving field. Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of new products and therapies which furnishes you with the details on cardiovascular pharmacology that you will refer to time and time again.

[ 查看全部 ]

投稿咨询加急咨询

Cardiovascular Drugs And Therapy期刊信息

ISSN：0920-3206
出版语言：English
是否OA：未开放
E-ISSN：1573-7241
出版地区：UNITED STATES
是否预警：否
出版商：Springer US
出版周期：Bimonthly
创刊时间：1987
开源占比：0.2471
Gold OA文章占比：26.52%
OA被引用占比：0.3466...
出版国人文章占比：0.14
出版撤稿占比：0
研究类文章占比：73.27%

Cardiovascular Drugs And Therapy CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

8.3

0.973

0.814

学科类别	分区	排名	百分位
大类：Medicine 小类：Pharmacology (medical)	Q1	35 / 272	87%
大类：Medicine 小类：Cardiology and Cardiovascular Medicine	Q1	57 / 387	85%
大类：Medicine 小类：Pharmacology	Q1	65 / 313	79%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Cardiovascular Drugs And Therapy中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	PHARMACOLOGY & PHARMACY 药学 CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统	3区 4区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 PHARMACOLOGY & PHARMACY 药学	3区 3区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 PHARMACOLOGY & PHARMACY 药学	3区 3区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 PHARMACOLOGY & PHARMACY 药学	3区 2区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 PHARMACOLOGY & PHARMACY 药学	3区 3区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	PHARMACOLOGY & PHARMACY 药学 CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统	2区 3区

Cardiovascular Drugs And Therapy JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q2	67 / 220	69.8%
学科：PHARMACOLOGY & PHARMACY	SCIE	Q2	126 / 354	64.5%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q2	69 / 220	68.86%
学科：PHARMACOLOGY & PHARMACY	SCIE	Q2	125 / 354	64.83%

Cardiovascular Drugs And Therapy历年数据统计

影响因子

中科院分区

Cardiovascular Drugs And Therapy中国学者发文选摘

1、The Function and Therapeutic Potential of Circular RNA in Cardiovascular Diseases
Author: Wang, Kai; Gao, Xiang-Qian; Wang, Tao; Zhou, Lu-Yu

Journal: CARDIOVASCULAR DRUGS AND THERAPY. 2023; Vol. 37, Issue 1, pp. 181-198. DOI: 10.1007/s10557-021-07228-5
2、The Function and Regulation of Platelet P2Y12 Receptor
Author: Li, Xiaohua; Zhang, Guoxing; Cao, Xia

Journal: CARDIOVASCULAR DRUGS AND THERAPY. 2023; Vol. 37, Issue 1, pp. 199-216. DOI: 10.1007/s10557-021-07229-4
3、Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic Review and Network Meta-Analysis
Author: Xu, Wenlin; Lv, Meina; Wu, Shuyi; Jiang, Shaojun; Zeng, Zhiwei; Fang, Zongwei; Qian, Jiafen; Chen, Mingrong; Chen, Jiana; Zhang, Jinhua

Journal: CARDIOVASCULAR DRUGS AND THERAPY. 2023; Vol. 37, Issue 2, pp. 363-377. DOI: 10.1007/s10557-021-07232-9
4、Caspofungin Suppresses Brain Cell Necroptosis in Ischemic Stroke Rats via Up-Regulation of Pellino3
Author: Zhang, Yi-Yue; Tian, Jing; Peng, Zi-Mei; Liu, Bin; Peng, Ya-Wei; Zhang, Xiao-Jie; Hu, Zhong-Yang; Luo, Xiu-Ju; Peng, Jun

Journal: CARDIOVASCULAR DRUGS AND THERAPY. 2023; Vol. 37, Issue 1, pp. 9-23. DOI: 10.1007/s10557-021-07231-w
5、Nicorandil Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats, as Evaluated by 7 T Cardiovascular Magnetic Resonance Imaging
Author: Wan, Yixuan; He, Bo; Zhu, Dongyong; Wang, Lei; Huang, Ruijue; Wang, Shiyu; Wang, Chunhua; Zhang, Mengdi; Ma, Lu; Gao, Fabao

Journal: CARDIOVASCULAR DRUGS AND THERAPY. 2023; Vol. 37, Issue 1, pp. 39-51. DOI: 10.1007/s10557-021-07252-5
6、Early Guideline-Directed Medical Therapy and in-Hospital Major Bleeding Risk in ST-Elevation Myocardial Infarction Patients Treated with Percutaneous Coronary Intervention: Findings from the CCC-ACS Project
Author: Li, Ziping; Yang, Pengfei; Geru, A.; Sun, Haonan; Liu, Hangkuan; Song, Xiwen; Jin, Zhengyang; Li, Linjie; Hao, Yongchen; Li, Yongle; Liu, Jing; Zhao, Dong; Zhou, Xin; Yang, Qing

Journal: CARDIOVASCULAR DRUGS AND THERAPY. 2023; Vol. 37, Issue 1, pp. 117-127. DOI: 10.1007/s10557-021-07201-2
7、Differential Expression of LOXL1-AS1 in Coronary Heart Disease and its Regulatory Mechanism in ox-LDL-Induced Human Coronary Artery Endothelial Cell Pyroptosis
Author: Song, Bangrong; Dang, Haiming; Dong, Ran

Journal: CARDIOVASCULAR DRUGS AND THERAPY. 2023; Vol. 37, Issue 1, pp. 75-87. DOI: 10.1007/s10557-021-07274-z
8、Protective Roles of Xijiao Dihuang Tang on Coronary Artery Injury in Kawasaki Disease
Author: Zhang, Jian; Zhuge, Yingzhi; Rong, Xing; Ni, Chao; Niu, Chao; Wen, Zhengwang; Lin, Hongzhou; Chu, Maoping; Jia, Chang

Journal: CARDIOVASCULAR DRUGS AND THERAPY. 2023; Vol. 37, Issue 2, pp. 257-270. DOI: 10.1007/s10557-021-07277-w